SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-07-000093
Filing Date
2007-12-28
Accepted
2007-12-28 06:59:13
Documents
4
Period of Report
2007-12-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K EMPLOYMENT AGREEMENTS CHANGES employmentagreements8k.htm 8-K 30098
2 CHRISTOPHER SCHABER EMPLOYMENT AGREEMENT schaberempagree.htm EX-10.1 55108
3 EVAN MYRIANTHOPOULOS EMPLOYMENT AGREEMENT myrianthopoulosagree.htm EX-10.2 52708
4 JAMES CLAVIJO EMPLOYMENT AGREEMENT clavijoagree.htm EX-10.3 54589
  Complete submission text file 0000812796-07-000093.txt   194285
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 071330240
SIC: 2834 Pharmaceutical Preparations